JP2024513039A5 - - Google Patents
Info
- Publication number
- JP2024513039A5 JP2024513039A5 JP2023560534A JP2023560534A JP2024513039A5 JP 2024513039 A5 JP2024513039 A5 JP 2024513039A5 JP 2023560534 A JP2023560534 A JP 2023560534A JP 2023560534 A JP2023560534 A JP 2023560534A JP 2024513039 A5 JP2024513039 A5 JP 2024513039A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antibody preparation
- approximately
- seq
- preparation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163170042P | 2021-04-02 | 2021-04-02 | |
| US63/170,042 | 2021-04-02 | ||
| PCT/CN2022/084711 WO2022206938A1 (en) | 2021-04-02 | 2022-04-01 | High concentration antibody formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024513039A JP2024513039A (ja) | 2024-03-21 |
| JP2024513039A5 true JP2024513039A5 (https=) | 2025-04-04 |
Family
ID=83458085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560534A Pending JP2024513039A (ja) | 2021-04-02 | 2022-04-01 | 高濃度の抗体製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240191000A1 (https=) |
| EP (1) | EP4313145A4 (https=) |
| JP (1) | JP2024513039A (https=) |
| KR (1) | KR20230166103A (https=) |
| CN (1) | CN117083085A (https=) |
| CA (1) | CA3215242A1 (https=) |
| TW (1) | TW202304509A (https=) |
| WO (1) | WO2022206938A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3000B1 (ar) * | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
| EP2401300B1 (en) * | 2009-02-25 | 2018-01-10 | Academia Sinica | ANTI-C[epsilon]mX ANTIBODIES CAPABLE OF BINDING TO HUMAN mIgE ON B LYMPHOCYTES |
| CN105143260A (zh) * | 2013-03-13 | 2015-12-09 | 中央研究院 | 特异于人类膜结合型IgE的CEMX上的新颖抗原决定部位的抗体及其用于治疗IgE介导的疾病的用途 |
| WO2019085902A1 (en) * | 2017-10-31 | 2019-05-09 | Fountain Biopharma Inc. | Treating ige-mediated allergic diseases |
-
2022
- 2022-04-01 EP EP22779118.3A patent/EP4313145A4/en active Pending
- 2022-04-01 WO PCT/CN2022/084711 patent/WO2022206938A1/en not_active Ceased
- 2022-04-01 KR KR1020237036831A patent/KR20230166103A/ko active Pending
- 2022-04-01 US US18/553,228 patent/US20240191000A1/en active Pending
- 2022-04-01 TW TW111112918A patent/TW202304509A/zh unknown
- 2022-04-01 CN CN202280023299.5A patent/CN117083085A/zh active Pending
- 2022-04-01 JP JP2023560534A patent/JP2024513039A/ja active Pending
- 2022-04-01 CA CA3215242A patent/CA3215242A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7080263B2 (ja) | 高濃度の抗ｖｅｇｆ抗体を含有する安定状態のタンパク質溶液製剤 | |
| CA3044502A1 (en) | Stable aqueous anti-c5 antibody composition | |
| JP2022105056A (ja) | 高濃度の抗ｖｅｇｆ抗体を含有するタンパク質溶液製剤 | |
| JP2024513039A5 (https=) | ||
| TWI726426B (zh) | 包含抗ｏｘ４０抗體的製劑、其製備方法及其用途 | |
| US20240175027A1 (en) | Anti-c5 antibody/c5 irna co-formulations and combination therapies | |
| RU2829156C2 (ru) | Композиция, содержащая анти-pd-1/her2 биспецифическое антитело, способ ее получения и ее использование | |
| CA2966758C (en) | Stable protein solution formulation containing high concentration of an anti-vegf antibody | |
| CN116803420A (zh) | 靶向PD-1和TGFβ的双功能蛋白药物组合物及其用途 | |
| EA042435B1 (ru) | Стабильный препарат раствора белка, содержащего анти-vegf антитело в высокой концентрации |